Diebold Nixdorf DBD Cash & Equivalents
Cash & Equivalents at other companies
Other financials
Where this comes from
Reported directly by Diebold Nixdorf in its filing.
Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.
The official record: Diebold Nixdorf’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Diebold Nixdorf's cash & equivalents.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Diebold Nixdorf's cash & equivalents?
- Diebold Nixdorf (DBD) reported cash & equivalents of $373.6M in Q1 2026.
- How has Diebold Nixdorf's cash & equivalents changed year-over-year?
- Diebold Nixdorf's cash & equivalents increased by 16.7% year-over-year, from $320.2M to $373.6M.
- What is the long-term trend for Diebold Nixdorf's cash & equivalents?
- Over 5 years (2020 to 2025), Diebold Nixdorf's cash & equivalents has grown at a 3.6% compound annual growth rate (CAGR), from $324.5M to $387.3M.
- What does cash & equivalents mean?
- Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.